Biora Therapeutics Presents Data on the BioJet™ Systemic Oral Delivery Platform at the American Diabetes Association 83rd Scientific SessionsGlobeNewsWire • 06/26/23
Biora Therapeutics Announces Closing of $8 Million Registered Direct Offering of Common Stock and Warrants Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 06/14/23
Biora Therapeutics Announces $8 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 06/13/23
Biora Therapeutics to Present Preclinical Data on the BioJet™ Systemic Oral Delivery Platform at the 59th Annual Meeting of the European Association for the Study of DiabetesGlobeNewsWire • 06/08/23
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial ResultsGlobeNewsWire • 05/15/23
Biora Therapeutics to Report First Quarter 2023 Financial Results and Provide Corporate UpdateGlobeNewsWire • 05/08/23
Biora Therapeutics to Participate in Crohn's & Colitis Foundation's IBD Innovate ConferenceGlobeNewsWire • 04/20/23
Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial ResultsGlobeNewsWire • 03/30/23
Biora Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate UpdateGlobeNewsWire • 03/23/23
Biora Therapeutics Announces Bioavailability Results for Oral Delivery of GLP-1 Receptor AgonistGlobeNewsWire • 02/23/23
Biora Therapeutics Announces Improved Bioavailability Results for its Systemic Delivery PlatformGlobeNewsWire • 02/16/23
Biora Therapeutics, Inc. (BIOR) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Zacks Investment Research • 02/02/23
Biora Therapeutics Presents Data from Device Performance Study with Repeat Doses in Both Fasted and Fed States at Crohn's & Colitis CongressGlobeNewsWire • 01/19/23
Biora Therapeutics Receives Pre-IND Feedback from FDA and Provides Update on Key Programs for 2023GlobeNewsWire • 01/09/23
Biora Therapeutics Announces Two Poster Presentations at the Crohn's & Colitis CongressGlobeNewsWire • 12/08/22